Q1 2026 Holdings
Filed 2026-05-13 | 52 holdings | $505.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-05-28) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH)A | COM | 252828108 | $176.6M | 2,104,184 | 34.9% |
| CG Oncology Inc(CGON)A | COM | 156944100 | $87.2M | 1,288,948 | 17.3% |
| Oruka Therapeutics Inc(ORKA)A | COM | 687604108 | $37.3M | 760,424 | 7.4% |
| Perspective Therapeutics Inc(CATX)A | COM NEW | 46489V302 | $25.2M | 6,049,999 | 5.0% |
| Jade Biosciences Inc(JBIO)A | COM NEW | 008064206 | $19.7M | 1,400,708 | 3.9% |
| Enliven Therapeutics Inc(ELVN)A | COM | 29337E102 | $15.7M | 400,000 | 3.1% |
| Teva Pharm ADR(TEVA)A | COM | 881624209 | $13.6M | 450,100 | 2.7% |
| Context Therapeutics Inc(CNTX)A | COM | 21077P108 | $13.1M | 4,998,267 | 2.6% |
| Repligen Corp(RGEN)A | COM | 759916109 | $9.2M | 77,800 | 1.8% |
| Palvella Therapeutics Inc(PVLA)A | COM | 697947109 | $8.7M | 70,000 | 1.7% |
| Medtronic Inc(MDT)A | SHS | G5960L103 | $8.7M | 100,000 | 1.7% |
| VIR Biotechnology Inc(VIR)A | COM | 92764N102 | $8.5M | 950,000 | 1.7% |
| Aktis Oncology Inc(AKTS)A | COM | 01021M104 | $8.4M | 468,566 | 1.7% |
| Immunic Inc(IMUX)A | COM | 4525EP101 | $7.4M | 6,699,411 | 1.5% |
| Humana Inc(HUM) | COM | 444859102 | $5.9M | 25,000 | 1.2% |
| Dexcom(DXCM)A | COM | 252131107 | $5.7M | 90,000 | 1.1% |
| Encompass Health Corp(EHC)A | COM | 29261A100 | $4.1M | 42,000 | 0.8% |
| Boston Scientific Corporation(BSX)A | COM | 101137107 | $3.8M | 60,000 | 0.7% |
| Tenax Therapeutics Inc(TENX)A | COM NEW | 88032L605 | $3.5M | 215,934 | 0.7% |
| Gilead Sciences Inc(GILD)A | COM | 375558103 | $2.8M | 20,000 | 0.6% |
| Phathom Pharmaceuticals Inc(PHAT)A | COM | 71722W107 | $2.8M | 249,390 | 0.5% |
| Karyopharm Therapeutics Inc(KPTI)A | COM NEW | 48576U205 | $2.6M | 463,741 | 0.5% |
| Centene Corp(CNC)A | COM | 15135B101 | $2.3M | 70,000 | 0.5% |
| Satellos Bioscience Inc(MSLE)A | COM | 80401L803 | $2.2M | 387,769 | 0.4% |
| Scynexis Inc(SCYX)A | COM NEW | 811292200 | $1.9M | 2,081,660 | 0.4% |
| Natera Inc(NTRA)A | COM | 632307104 | $1.8M | 9,000 | 0.4% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $1.8M | 16,000 | 0.4% |
| Kenvue Inc ORD(KVUE)A | COM | 49177J102 | $1.7M | 100,000 | 0.3% |
| Insulet Corp(PODD) | COM | 45784P101 | $1.7M | 10,000 | 0.3% |
| Corvus Pharmaceuticals Inc(CRVS)A | COM | 221015100 | $1.7M | 115,000 | 0.3% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.7M | 10,000 | 0.3% |
| Hims & Hers Health Inc(HIMS)A | COM CL A | 433000106 | $1.6M | 75,000 | 0.3% |
| Revolution Medicines Inc(RVMD)A | COM | 76155X100 | $1.5M | 15,000 | 0.3% |
| Structure Therapeutics Inc(GPCR)A | SPONSORED ADS | 86366E106 | $1.4M | 30,000 | 0.3% |
| Genmab A/S(GMAB)A | SPONSORED ADS | 372303206 | $1.3M | 50,000 | 0.3% |
| Corcept Thera(CORT)A | COM | 218352102 | $1.2M | 30,000 | 0.2% |
| Tempus AI Inc(TEM)A | CL A | 88023B103 | $1.1M | 25,000 | 0.2% |
| Abivax SA(ABVX)A | SPONSORED ADS | 00370M103 | $1.1M | 10,000 | 0.2% |
| Unitedhealth GRP(UNH)A | COM | 91324P102 | $1.0M | 3,800 | 0.2% |
| Intellia Therapeutics Inc(NTLA)A | COM | 45826J105 | $961.5K | 75,000 | 0.2% |
| Oddity Tech LTD(ODD)A | SHS CL A | M7518J104 | $936.6K | 70,000 | 0.2% |
| Moonlake Immunotherapeutics(MLTX)A | CLASS A ORD | 61559X104 | $932.0K | 50,000 | 0.2% |
| Abbott Laboratories(ABT) | COM | 002824100 | $907.9K | 10,000 | 0.2% |
| Peloton Interactive Inc(PTON)A | CL A COM | 70614W100 | $858.0K | 200,000 | 0.2% |
| Anteris Technologies Global(AVR)A | COM | 03675P102 | $832.5K | 150,000 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $711.1K | 10,000 | 0.1% |
| Arbutus Biopharma Corp(ABUS)A | COM | 03879J100 | $562.5K | 125,000 | 0.1% |
| Bridgebio Oncology Therapeutic(BBOT)A | COM | 107924102 | $392.5K | 43,853 | 0.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $352.8K | 15,000 | 0.1% |
| Acadia Pharm(ACAD)A | COM | 004225108 | $288.6K | 12,967 | 0.1% |